EA200301224A1 - Способ получения имипенема - Google Patents

Способ получения имипенема

Info

Publication number
EA200301224A1
EA200301224A1 EA200301224A EA200301224A EA200301224A1 EA 200301224 A1 EA200301224 A1 EA 200301224A1 EA 200301224 A EA200301224 A EA 200301224A EA 200301224 A EA200301224 A EA 200301224A EA 200301224 A1 EA200301224 A1 EA 200301224A1
Authority
EA
Eurasian Patent Office
Prior art keywords
imipenem
obtaining
effective
cost
improved
Prior art date
Application number
EA200301224A
Other languages
English (en)
Other versions
EA007252B1 (ru
Inventor
Ятендра Кумар
Неера Тевари
Бишва Пракаш Рай
Original Assignee
Рэнбакси Лабораториз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рэнбакси Лабораториз Лимитед filed Critical Рэнбакси Лабораториз Лимитед
Publication of EA200301224A1 publication Critical patent/EA200301224A1/ru
Publication of EA007252B1 publication Critical patent/EA007252B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Настоящее изобретение относится к улучшенному, эффективному с точки зрения стоимости и выгодному в промышленном масштабе способу получения имипенема.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200301224A 2001-05-18 2002-05-15 Способ получения имипенема EA007252B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN594DE2001 2001-05-18
PCT/IB2002/001670 WO2002094828A1 (en) 2001-05-18 2002-05-15 Process for the preparation of imipenem

Publications (2)

Publication Number Publication Date
EA200301224A1 true EA200301224A1 (ru) 2004-12-30
EA007252B1 EA007252B1 (ru) 2006-08-25

Family

ID=11097061

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200301224A EA007252B1 (ru) 2001-05-18 2002-05-15 Способ получения имипенема

Country Status (19)

Country Link
US (1) US7462712B2 (ru)
EP (1) EP1395587B1 (ru)
JP (1) JP2005508860A (ru)
KR (1) KR20040002973A (ru)
CN (1) CN1694885A (ru)
AR (1) AR035978A1 (ru)
AT (1) ATE437879T1 (ru)
BR (1) BR0209842A (ru)
CA (1) CA2447227A1 (ru)
DE (1) DE60233130D1 (ru)
DK (1) DK1395587T3 (ru)
EA (1) EA007252B1 (ru)
ES (1) ES2328117T3 (ru)
MX (1) MXPA03010498A (ru)
NO (1) NO20035136D0 (ru)
PL (1) PL370705A1 (ru)
PT (1) PT1395587E (ru)
WO (1) WO2002094828A1 (ru)
ZA (1) ZA200308958B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL370705A1 (en) * 2001-05-18 2005-05-30 Ranbaxy Laboratories Limited Process for the preparation of imipenem
MXPA06001115A (es) 2003-12-09 2006-04-11 Choongwae Pharm Co Un proceso nuevo para la preparacion de imipenem.
WO2006035300A2 (en) * 2004-09-30 2006-04-06 Ranbaxy Laboratories Limited A process for the preparation of meropenem
WO2010146449A1 (en) * 2009-06-18 2010-12-23 Orchid Chemicals And Pharmaceuticals Limited An improved process for the preparation of imipenam
CN101921275B (zh) * 2010-07-16 2012-09-26 深圳市海滨制药有限公司 一种制备亚胺培南的方法
CN101921273B (zh) * 2010-07-16 2012-09-26 深圳市海滨制药有限公司 一种制备亚胺培南的方法
CN101921274B (zh) * 2010-07-16 2012-09-26 深圳市海滨制药有限公司 一种制备亚胺培南的方法
EP2946006B1 (en) 2013-01-18 2019-04-10 Codexis, Inc. Engineered biocatalysts useful for carbapenem synthesis
CN110790765B (zh) * 2018-08-02 2022-08-05 江苏瑞科医药科技有限公司 一种亚胺培南的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194047A (en) 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4292436A (en) 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
US4745188A (en) * 1980-11-21 1988-05-17 Merck & Co., Inc. Process for preparing 3-substituted-6-substituted-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
US4374772A (en) * 1981-03-19 1983-02-22 Merck & Co., Inc. Process for the preparation of N-formimidoyl thienamycin and reagents therefor
US4640915A (en) * 1982-03-29 1987-02-03 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid derivatives
US4644061A (en) * 1982-09-28 1987-02-17 Bristol-Myers Company Carbapenem antibiotics
US4782051A (en) * 1985-06-10 1988-11-01 Merck & Co., Inc. 2-aza-substituted 1-carbadethiapen-2-em-3 carboxylic acids
US4894450A (en) * 1987-05-11 1990-01-16 Merck & Co., Inc. Process for 2-(aminoalkylthio) carbapenems
US5672701A (en) * 1990-01-16 1997-09-30 Bristol-Myers Squibb Company 4-substituted alkyl carbapenem antibiotics
CA2117899A1 (en) * 1992-04-13 1993-10-28 Masayoshi Murata Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents
US5245069A (en) * 1992-10-27 1993-09-14 Merck & Co., Inc. Process for the preparation of bis(aryl)-phosphorohalidates
IN191798B (ru) * 2000-11-03 2004-01-03 Ranbaxy Lab Ltd
OA12608A (en) * 2001-05-18 2006-06-08 Ranbaxy Lab Ltd Process for the isolation of crystalline imiponem.
PL370705A1 (en) * 2001-05-18 2005-05-30 Ranbaxy Laboratories Limited Process for the preparation of imipenem
MXPA06001115A (es) * 2003-12-09 2006-04-11 Choongwae Pharm Co Un proceso nuevo para la preparacion de imipenem.

Also Published As

Publication number Publication date
PT1395587E (pt) 2009-09-03
DE60233130D1 (de) 2009-09-10
EP1395587A1 (en) 2004-03-10
US20040220168A1 (en) 2004-11-04
CN1694885A (zh) 2005-11-09
AR035978A1 (es) 2004-07-28
KR20040002973A (ko) 2004-01-07
NO20035136D0 (no) 2003-11-18
DK1395587T3 (da) 2009-10-12
CA2447227A1 (en) 2002-11-28
WO2002094828A1 (en) 2002-11-28
ZA200308958B (en) 2004-07-19
EP1395587B1 (en) 2009-07-29
PL370705A1 (en) 2005-05-30
US7462712B2 (en) 2008-12-09
EA007252B1 (ru) 2006-08-25
BR0209842A (pt) 2005-01-04
MXPA03010498A (es) 2004-05-27
JP2005508860A (ja) 2005-04-07
ATE437879T1 (de) 2009-08-15
EP1395587A4 (en) 2004-09-15
ES2328117T3 (es) 2009-11-10

Similar Documents

Publication Publication Date Title
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
BRPI0414599A (pt) pirrol-indóis substituìdos
EA200400252A1 (ru) Стабильная полиморфная модификация флибансерина, способ её промышленного получения и её применение для получения лекарственных средств
EA201000496A1 (ru) Замещенное соединение миноциклина, способ получения замещенных соединений миноциклина (варианты)
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
NO20091976L (no) Nye forbindelser
MXPA03011329A (es) Antiinfecciosos novedosos.
EA200401157A1 (ru) N-аминоацетилпирролидин-2-карбонитрилы и их применение в качестве ингибиторов ddp-iv
EA200400682A1 (ru) Способ получения кристаллического имипенема
EA200201245A1 (ru) Способы получения и промежуточные соединения для получения противораковых соединений
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
EA200401551A1 (ru) Получение сульфинилацетамида
EA200400006A1 (ru) Бензоилсульфонамиды и сульфонилбензамидины для применения в качестве противоопухолевых агентов
EA200100012A1 (ru) Мостиковые инденопирролокарбазолы
EA200401242A1 (ru) Способ получения цитотоксических лимфоцитов
EA200400487A1 (ru) Фармацевтическая композиция длительного высвобождения, содержащая метформин
EA200301224A1 (ru) Способ получения имипенема
EA199800792A1 (ru) Способы получения промежуточных соединений для пестицидов
EA200400195A1 (ru) Способ репродукции вируса
EA200500486A1 (ru) Новые фармацевтические составы модафинила
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
EA200400782A1 (ru) Композиция изотретиноина с измельчением компонентов до степени наночастиц
EA200300520A1 (ru) Способ получения кристаллического моногидрата n-формимидоилтиенамицина (моногидрата имипенема)
EA200000322A1 (ru) Способ синтеза производных хинолина
EA199900741A1 (ru) Способ получения эпросартана

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU